AI주식인사이트AI Stock Insight
C

케어젠

214370KOSDAQ

42.5 / 100

Reference Date: 2026-10-23

Financial Score15.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 9.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Caregen develops and sells pharmaceuticals, health supplements, medical devices, and cosmetics based on biomimetic peptides and growth factor proteins, leveraging a large peptide library with over 860 patents. The company offers key products such as blood sugar regulators, muscle health supplements, and weight management solutions, and is expanding into new drug pipelines for conditions like macular degeneration, diabetes, and hair loss through global sales in 130 countries.

Number of Employees

201people

Average Salary

50.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
90.63Industry Average 15.000.0Point

6.0x industry avg (risky)

PBR
9.42Industry Average 1.200.0Point

7.9x industry avg (risky)

ROE
9.23Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
4.90Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼3.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼27.8% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 13.9% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 37,250Won52-week high 150,10052-week low 36,400
1-month return1.0Point

1m -9.70% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-01
  • Neutral주식등의대량보유상황보고서(일반)2026-09-29
  • Neutral주식등의대량보유상황보고서(일반)2026-09-28